MYCR

Mycronic

Market Cap 9,679.0M

Mid Cap-bolaget Mycronic utvecklar system för elektroniktillverkning och säljer dessa direkt eller via distributionspartners till hundratals kunder i hela världen. FoU sker dock till största del på bolagets huvudkontor i Täby (Stockholm). Mycronic har funnits i närmare 30 år men i nuvarande form sedan 2009 då mönsterritar-tillverkaren Micronic förvärvade Mydata med verksammet inom ytmontering. Mycronics verksamheter delas in i de två affärsområdena Pattern Generators (PG) och Assembly Solutions (AS) där förvärven av Axxon och AEi ingår i det senast nämnda segmentet. . Mycronics främsta styrka är att bolaget har en marknadsandel på 100 procent vad gäller maskritare för bildskärmar och följaktligen har varenda smartphone och läsplatta etc. gjorts med hjälp av bolagets utrustning. Vi bedömer att detta är en nischmarknad som inte är stor nog för att nära en till aktör. Inom affärsområde AS har Mycronic en andel på 1-2 procent av totala ytmonteringsmarknaden men inom bolagets nisch (high mix) uppskattar vi marknadsandelen till över 20 procent. Investeringar i utveckling för miljarder SEK har gjorts och ett stort antal patent har erhållits, vilket på sätt och vis också visar på bolagets svaghet. Teknikrisken tvingar bolaget att fortsätta att kontinuerligt investera tungt för att fortsätta vara relevant.

+ more

Redeye Research

Reports

Notes

Today
Day High
100.50
99.2
Day Low
98.50
Day Open
100.90
Prev Close
98.85
VWAP
99.8
Volume
94K
Turnover
9.394M
Top Broker
JPM
VWAP
100.0
Avg Volume
185K
Avg Turnover
18.453M
Top Brokers
GSI/MSI
VWAP
101.2
Avg Volume
283K
Avg Turnover
28.590M
Top Brokers
DDB/ENS
VWAP
100.4
Avg Volume
300K
Avg Turnover
30.095M
Top Brokers
ENS/DDB
52 week summary
Price Range
71.5
Last
118.3
Beta
N/A
Market Cap
9,679.0M
Total Return
23.9%
Trailing P/E
15.7
Div Yield
2.2%
Shares Outstanding
97.9M
Next Earnings Date
13 Jul
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months -8.6%
Change 12 Months 31.6%
Volume Trend
Average Volume 10 vs 60 Days -57.4%
Price VS
52 Week High -16.1%
50 Day Moving Average 0.7%
200 Day moving Average 0.7%

Add article markers

Compare Mycronic to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Lena Olving, CEO
  • Torbjörn Wingårdh, CFO
  • Executive board
  • Patrik Tigerschiöld, Chairman of the board
Last updated: 2018-01-29 Source: Redeye
Major Owners Equity Votes
Bure Equity 29.9%
29.9%
Fjärde AP-fonden 9.2%
9.2%
Swedbank Robur Fonder 7.9%
7.9%
Handelsbanken Fonder 3.6%
3.6%
Handelsbanken Fonder 3.4%
3.4%
SEB Fonder 3.1%
3.1%
Catella Fonder 2.9%
2.9%
Andra AP-fonden 2.8%
2.8%
Avanza Pension 1.8%
1.8%
Vanguard 1.7%
1.7%
Last updated: 2018-04-19 Source: Redeye/Holdings
Timeframe Transactions Net Shares
Last 12 weeks
1 Purchases
2,000
0 Sales
0
Last 24 weeks
1 Purchases
2,000
0 Sales
0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Insider trades are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • 35.9%
  • 43.7%
  • 81.0%
  • 30.0%
  • 29.8%
  • 24.4%
  •  
  • 4.52
  • 4.52
  • 1.50
  •  
  • 97.9
  •  
  • 7,168.5
  • 18.2
  • 18.2
  • 4.4
  • 3.9
  • 13.2
  • 13.3
  • 6.4
  •  
  • 72.1%
  • 0.2%
  • -885
  • 370
  • 1.0
  • 2015
  •  
  •  
  • 898
  • 271
  • 276
  • 55
  • 1,500
  •  
  • 38
  • 0
  • 0
  • 64
  • 0
  • 59
  • 40
  • 201
  • 41
  • 1,742
  •  
  •  
  • 12
  • 91
  • 347
  • 450
  • 0
  • 15
  • 0
  • 465
  • 0
  • 21
  • 1,256
  • 0
  • 1,256
  • 1,742
  • 2015
  • 1,815
  • -1,270
  • -4
  • 540
  • -98
  • 442
  • 4
  • 447
  • 111
  • -20
  • 618
  • 2015 Q2
  • 285
  • -280
  • 4
  • -3
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • -1
  • 1
  • 2015 Q3
  • 605
  • -343
  • 262
  • 0
  • 0
  • 0
  • 262
  • 0
  • 0
  • 0
  • 262
  • -34
  • 228
  • 2015 Q4
  • 621
  • -372
  • 250
  • 2
  • 0
  • 0
  • 251
  • 0
  • 0
  • 0
  • 252
  • -56
  • 195
  • 2016
  •  
  • 39.5%
  • 51.2%
  • 142.4%
  • 30.1%
  • 29.8%
  • 22.7%
  •  
  • 5.37
  • 5.37
  • 2.00
  •  
  • 97.9
  •  
  • 9,398.0
  • 18.2
  • 18.2
  • 4.1
  • 4.1
  • 13.5
  • 13.6
  • 6.8
  •  
  • 51.2%
  • 0.1%
  • -198
  • 1,214
  • 0.8
  • 2016
  •  
  •  
  • 209
  • 597
  • 575
  • 151
  • 1,531
  •  
  • 60
  • 0
  • 0
  • 748
  • 293
  • 43
  • 23
  • 1,168
  • 57
  • 2,755
  •  
  •  
  • 11
  • 186
  • 812
  • 1,009
  • 0
  • 76
  • 0
  • 1,085
  • 0
  • 259
  • 1,412
  • 0
  • 1,412
  • 2,755
  • 2016
  • 2,319
  • -1,622
  • -7
  • 691
  • -163
  • 527
  • 7
  • 534
  • -159
  • -974
  • -316
  • 2016 Q1
  • 344
  • -314
  • 30
  • 1
  • 0
  • 0
  • 32
  • 0
  • 0
  • 0
  • 31
  • -8
  • 24
  • 2016 Q2
  • 463
  • -357
  • 106
  • 0
  • 0
  • 0
  • 106
  • 0
  • 0
  • 0
  • 106
  • -24
  • 82
  • 2016 Q3
  • 497
  • -345
  • 152
  • -4
  • 0
  • 0
  • 148
  • 0
  • -1
  • 0
  • 148
  • -33
  • 115
  • 2016 Q4
  • 1,016
  • -606
  • 410
  • -5
  • -2
  • 0
  • 405
  • 0
  • -1
  • 0
  • 404
  • -99
  • 306
  • 2017
  •  
  • 39.0%
  • 51.9%
  • 52.1%
  • 29.4%
  • 28.3%
  • 20.9%
  •  
  • 6.40
  • 6.40
  • 2.20
  •  
  • 97.9
  •  
  • 7,816.6
  • 13.8
  • 13.8
  • 2.9
  • 2.6
  • 8.9
  • 9.2
  • 4.8
  •  
  • 55.6%
  • 0.2%
  • -800
  • 1,000
  • 0.9
  • 2017
  •  
  •  
  • 813
  • 512
  • 589
  • 138
  • 2,052
  •  
  • 70
  • 0
  • 0
  • 742
  • 255
  • 40
  • 17
  • 1,124
  • 63
  • 3,239
  •  
  •  
  • 13
  • 155
  • 883
  • 1,050
  • 0
  • 119
  • 0
  • 1,169
  • 0
  • 269
  • 1,800
  • 0
  • 1,800
  • 3,239
  • 2017
  • 3,001
  • -2,119
  • -34
  • 848
  • -215
  • 633
  • 34
  • 666
  • 122
  • 11
  • 846
  • 2017 Q1
  • 676
  • -513
  • 164
  • -5
  • -2
  • 0
  • 158
  • 0
  • -3
  • 0
  • 156
  • -44
  • 112
  • 2017 Q2
  • 910
  • -590
  • 320
  • -5
  • -2
  • 0
  • 314
  • 0
  • -2
  • 0
  • 312
  • -72
  • 241
  • 2017 Q3
  • 484
  • -410
  • 74
  • -11
  • -2
  • 0
  • 63
  • 0
  • -1
  • 0
  • 62
  • -21
  • 42
  • 2017 Q4
  • 931
  • -607
  • 324
  • -12
  • -3
  • 0
  • 312
  • 0
  • -3
  • 0
  • 309
  • -77
  • 232
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 Q1 E
  • 2018 Q2 E
  • 2018 Q3 E
  • 2018 Q4 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 Q1 E
  • 2019 Q2 E
  • 2019 Q3 E
  • 2019 Q4 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 Q1 E
  • 2020 Q2 E

Estimated Values are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-06-04 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.